Youming Peng Selected Research

Tonsillitis

6/2014	Study of tonsillectomy for IgA nephropathy patients: short- and longer-term observation.
5/2014	Expression and correlation analysis of IL-4, IFN-γ and FcαRI in tonsillar mononuclear cells in patients with IgA nephropathy.
1/2013	Activation of the interleukin-4/signal transducer and activator of transcription 6 signaling pathway and homeodomain-interacting protein kinase 2 production by tonsillar mononuclear cells in IgA nephropathy.
1/2013	Comparative study of bacterial strains and antibiotic susceptibility tests between chronic tonsillitis patients with IgA nephropathy and without nephritis.
9/2011	Expression of IgA class switching gene in tonsillar mononuclear cells in patients with IgA nephropathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Youming Peng Research Topics

Disease

21	IGA Glomerulonephritis (IGA Nephropathy) 01/2019 - 01/2007
11	Proteinuria 06/2019 - 05/2007
10	Fibrosis (Cirrhosis) 01/2020 - 05/2007
8	Peritoneal Fibrosis 07/2014 - 01/2005
5	Tonsillitis 06/2014 - 09/2011
4	Acute Kidney Injury (Acute Renal Failure) 01/2020 - 09/2009
4	Body Weight (Weight, Body) 01/2017 - 01/2008
3	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020 - 02/2015
3	Kidney Diseases (Kidney Disease) 08/2017 - 01/2013
3	Membranous Glomerulonephritis (Membranous Nephropathy) 10/2016 - 05/2013
3	Atherosclerosis 05/2013 - 10/2008
2	Nephritis 01/2022 - 01/2013
2	Chronic Renal Insufficiency 06/2020 - 11/2012
2	Infections 01/2020 - 07/2013
2	Hematuria 06/2019 - 01/2016
2	Inflammation (Inflammations) 02/2018 - 10/2002
2	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2017 - 01/2015
2	Nephrotic Syndrome (Syndrome, Nephrotic) 05/2014 - 06/2013
2	Glomerulonephritis 01/2014 - 01/2007
2	Chronic Kidney Failure (Chronic Renal Failure) 05/2013 - 01/2008
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Reperfusion Injury 12/2019
1	Lupus Nephritis 12/2018
1	Hypoxia (Hypoxemia) 11/2017
1	Hematoma 01/2016
1	Disease Progression 02/2015
1	Virus Diseases (Viral Diseases) 01/2015
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 09/2014
1	Thrombotic Thrombocytopenic Purpura 09/2014
1	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 05/2014
1	Sepsis (Septicemia) 01/2014
1	Multiple Organ Failure (MODS) 01/2014

Drug/Important Bio-Agent (IBA)

11	Immunoglobulin A (IgA)IBA 01/2019 - 01/2007
6	Urea (Carbamide)FDA LinkGeneric 01/2016 - 01/2008
5	Proteins (Proteins, Gene)FDA Link 06/2019 - 01/2010
5	Interleukin-4 (Interleukin 4)IBA 11/2015 - 01/2013
4	Glucose (Dextrose)FDA LinkGeneric 02/2018 - 05/2007
4	NitrogenIBA 01/2016 - 09/2014
4	CreatinineIBA 01/2015 - 01/2008
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2012
3	Uric Acid (Urate)IBA 01/2016 - 11/2012
3	LipopolysaccharidesIBA 05/2014 - 09/2011
3	Messenger RNA (mRNA)IBA 05/2014 - 05/2007
3	Small Interfering RNA (siRNA)IBA 03/2014 - 01/2005
3	Plasminogen Activator Inhibitor 1IBA 01/2014 - 10/2008
2	AlbuminsIBA 06/2020 - 05/2010
2	CateninsIBA 12/2019 - 07/2013
2	InflammasomesIBA 12/2018 - 01/2014
2	Saline SolutionIBA 01/2017 - 01/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017 - 01/2015
2	triptolideIBA 01/2016 - 01/2015
2	CytokinesIBA 04/2014 - 10/2002
2	Connective Tissue Growth FactorIBA 03/2014 - 03/2009
2	Serum AlbuminIBA 05/2013 - 01/2008
2	Endothelin-1 (Endothelin 1)IBA 05/2013 - 09/2010
2	Stem Cell FactorIBA 07/2010 - 01/2010
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 03/2009 - 05/2007
1	plasmin receptorIBA 01/2022
1	GlobulinsIBA 06/2020
1	trans-4-hydroxy-L-prolineIBA 01/2020
1	Golgi Matrix ProteinsIBA 01/2019
1	piperineIBA 12/2018
1	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2017
1	Mineralocorticoid Receptor AntagonistsIBA 08/2017
1	PolyphenolsIBA 01/2017
1	ResveratrolIBA 01/2017
1	Urokinase Plasminogen Activator ReceptorsIBA 01/2017
1	sphingosine kinaseIBA 01/2017
1	Phospholipase A2 ReceptorsIBA 10/2016
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2016
1	Immunoglobulins (Immunoglobulin)IBA 11/2015
1	Interleukin-6 (Interleukin 6)IBA 11/2015
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 06/2015
1	Gentamicins (Gentamicin)FDA LinkGeneric 04/2015
1	NPHS2 proteinIBA 02/2015
1	Galectin 1 (LGALS1)IBA 02/2015
1	polymeric IgAIBA 01/2015
1	Poly I-CIBA 01/2015
1	Immunoglobulin IsotypesIBA 01/2015
1	Double-Stranded RNA (RNA, Double Stranded)IBA 01/2015
1	astaxanthine (astaxanthin)IBA 01/2015
1	Capsaicin (Zostrix)FDA Link 10/2014
1	thiamine triphosphorate (TTP)IBA 09/2014
1	Toll-Like Receptors (Toll-Like Receptor)IBA 07/2014
1	Glycogen Synthase (Synthase I)IBA 07/2014
1	Phosphotransferases (Kinase)IBA 07/2014
1	MercuryIBA 05/2014
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2014
1	fibrin fragment D (D-dimer)IBA 01/2014
1	Heparin (Liquaemin)FDA LinkGeneric 01/2014
1	mangiferinIBA 01/2014

Therapy/Procedure

8	Renal Dialysis (Hemodialysis) 01/2020 - 10/2002
8	Therapeutics 08/2017 - 01/2012
5	Peritoneal Dialysis 01/2012 - 01/2005
4	Tonsillectomy 01/2016 - 01/2013
2	Drug Therapy (Chemotherapy) 01/2016 - 06/2014
1	Off-Pump Coronary Artery Bypass (Coronary Artery Bypass, Off Pump) 01/2020
1	Catheters 01/2020
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2020
1	Punctures 01/2016